| Christopher W Pottmeyer, MD | |
|
1 Saint Anthonys Way, Alton, IL 62002-4568 | |
| (618) 465-2571 | |
| Not Available |
| Full Name | Christopher W Pottmeyer |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1 Saint Anthonys Way, Alton, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215044490 | NPI | - | NPPES |
| P00449454 | Other | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher W Pottmeyer, MD Po Box 9040, Alton, IL 62002-9040 Ph: (618) 462-0499 | Christopher W Pottmeyer, MD 1 Saint Anthonys Way, Alton, IL 62002-4568 Ph: (618) 465-2571 |
News Archive
An aggregating protein causes many of the symptoms of Huntington's disease, an incurable and frequently fatal brain disorder. Mosaic winner Ahmad Aziz discovered that the abnormal protein also aggregates in the hypothalamus, the part of the brain that regulates the autonomic nervous system and the endocrine system.
Fighting chemoresistant cancer remains a huge challenge that scientists are tackling from as many angles as they can. One alternative approach involves pairing two groups of compounds - pain medicine and metal ions - that have individually shown promise as anti-cancer agents. Scientists report in the ACS journal Inorganic Chemistry that combining the two led to new compounds that could destroy drug-resistant cancer cells and leave most normal cells alone in lab tests.
The U.S. Food and Drug Administration today issued a Federal Register notice instructing companies to stop manufacturing and distributing certain unapproved drugs that contain oxycodone. The notice is part of the FDA's Unapproved Drugs Initiative to remove unapproved new drugs from the market.
Inhibitex, Inc. announced today that it has initiated a Phase 1b, multiple ascending dose (MAD) clinical trial of INX-189, its nucleotide polymerase inhibitor in development for the treatment of chronic infections caused by hepatitis C virus (HCV).
› Verified 7 days ago
Ibrahim B.i. Elayyan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Saint Anthonys Way, Alton, IL 62002 Phone: 314-317-0600 Fax: 314-317-0606 | |
Dr. Barry Michael Mossman, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Memorial Dr, Ste 220, Alton, IL 62002 Phone: 618-474-1723 Fax: 618-474-6989 | |
Dr. Matthew Austin Nations, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7240 | |
Mr. David Robert Riedel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Memorial Dr Ste 230, Alton, IL 62002 Phone: 618-463-7874 Fax: 618-463-7846 | |
Dr. Stanley J Sidwell Iv, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7240 Fax: 618-463-7216 | |
Dr. Edward B Blair Jr., M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2 Saint Anthonys Way, Suite 205, Alton, IL 62002 Phone: 618-462-2222 Fax: 618-463-5004 | |
Dr. William Ray Bartley, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Professional Dr, Suite 220, Alton, IL 62002 Phone: 618-463-8626 Fax: 618-463-8688 |